Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized study.

W L Ramseur, F Richards, H B Muss

    Cancer Treatment Reports
    |July 1, 1978
    PubMed
    Summary

    This study investigated chemoimmunotherapy for advanced melanoma. Adding bacillus Calmette-Guérin immunotherapy to dacarbazine and actinomycin D chemotherapy showed limited benefit, with similar complete response rates in both groups.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Johnson Noise <i>Thermometry</i>.

    Measurement science & technology·2024
    Same author

    The Boltzmann project.

    Metrologia·2019
    Same author

    Interruption of the transmission of Onchocerca volvulus in the Kashoya-Kitomi focus, western Uganda by long-term ivermectin treatment and elimination of the vector Simulium neavei by larviciding.

    Acta tropica·2016
    Same author

    The kelvin redefinition and its mise en pratique.

    Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2016
    Same author

    The disappearance of onchocerciasis from the Itwara focus, western Uganda after elimination of the vector Simulium neavei and 19 years of annual ivermectin treatments.

    Acta tropica·2013
    Same author

    Nitrogen mustard therapy; studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system.

    Journal of the American Medical Association·2010

    Area of Science:

    • Oncology
    • Immunology
    • Pharmacology

    Background:

    • Disseminated malignant melanoma is an advanced cancer stage with limited treatment options.
    • Chemotherapy regimens like dacarbazine (DTIC) and actinomycin D have been used, but response rates can be modest.
    • Immunotherapy aims to stimulate the immune system to fight cancer cells.

    Purpose of the Study:

    • To evaluate the efficacy of chemoimmunotherapy combining DTIC, actinomycin D, and bacillus Calmette-Guérin (BCG) in patients with disseminated malignant melanoma.
    • To compare the response rates of chemoimmunotherapy versus chemotherapy alone.

    Main Methods:

    • Twenty-eight patients with disseminated malignant melanoma were enrolled.
    • Patients received DTIC and actinomycin D chemotherapy every 5 weeks.

    Related Experiment Videos

  • Participants were randomized to receive either chemotherapy alone or chemotherapy plus intradermal BCG immunotherapy.

    • Main Results:

    • A total of 28 evaluable patients were analyzed.
    • One complete response (CR) was observed in the 13 patients receiving chemoimmunotherapy.
    • One CR was observed in the 15 patients receiving chemotherapy alone.
    • Both complete responses occurred in lymph node metastases.
    • No partial responses were observed in either group.

    Conclusions:

    • The addition of bacillus Calmette-Guérin immunotherapy to dacarbazine and actinomycin D chemotherapy did not significantly improve complete response rates in patients with disseminated malignant melanoma.
    • Chemoimmunotherapy demonstrated a similar efficacy to chemotherapy alone in this patient cohort.
    • Further research may be needed to explore novel immunotherapy combinations or alternative treatment strategies for advanced melanoma.